— Know what they know.
Not Investment Advice

OVID NASDAQ

Ovid Therapeutics Inc.
1W: -4.2% 1M: -8.1% 3M: -1.3% YTD: +28.4% 1Y: +38.6% 3Y: -34.9% 5Y: -37.6%
$2.26
+0.10 (+4.87%)
Pre-Market: $2.35 (+0.09, +3.98%)
Weekly Expected Move ±9.9%
$2 $2 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $441.4M mcap · 163M float · 1.28% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 54% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.6%), Ovid Therapeutics Inc. would be worth roughly what it owes.
Total debt $12.7M against a stock market value of $441.4M.
Distance to default 5.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.4M (short-term plus half of long-term), stock volatility 74.2%; Altman Z'' 7.19. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
⛅
Partly Cloudy
+3.1% YTD avg
Midterm Year
⛈️
Stormy
-47.7% YTD avg
2026 Now
☀️
Sunny
Above typical
20yr Avg YTD
+3.1%
Day 206 of 252
Midterm Year YTD
-47.7%
Presidential cycle avg
2026 YTD
+28.4%
Above 20yr avg
Typical Vol
72%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
-0.5%
Midterm
⛈️
-14.3%
44% win 65% vol
Feb
20yr
⛈️
-4.4%
Midterm
⛈️
-13.5%
33% win 78% vol
Mar
20yr
🌫️
-12.5%
Midterm
⛈️
-21.9%
44% win 86% vol
Apr
20yr
💨
-1.9%
Midterm
⛈️
-7.8%
67% win 74% vol
May
20yr
⛈️
-1.5%
Midterm
⛈️
-34.5%
40% win 66% vol
Jun
20yr
⛈️
-4.2%
Midterm
⛈️
-27.7%
40% win 117% vol
Jul
20yr
💨
+1.3%
Midterm
⛈️
-16.4%
50% win 77% vol
Aug
20yr
💨
+3.7%
Midterm
⛈️
-36.5%
40% win 108% vol
Sep
20yr
💨
+13.4%
Midterm
⛈️
-43.7%
40% win 78% vol
Oct
20yr
⛈️
+1.7%
Midterm
⛈️
-49.2%
20% win 72% vol
Now: -9.2%
Nov
20yr
💨
+9.1%
Midterm
⛈️
-53.0%
67% win 83% vol
Dec
20yr
⛈️
-16.2%
Midterm
⛈️
-17.4%
22% win 90% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +28.4%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms